March 15, 2005

Edmunds v. Levine, Southern District of Florida

By: Litigation Team

Executive Summary

Class of severely disabled Medicaid recipients challenged Florida’s decision to deny coverage of a prescription drug, Neurontin, for medically accepted indications that were cited in congressionally-recognized drug compendia, including neuropathic pain and certain psychiatric disorders, in violation of the Medicaid Act.

Partners: Florida Legal Services, Legal Aid Service of Broward County

Case: Covered Services, Federal and State Court Cases, Medicaid, Prescription Drugs

Related Content

December 3, 2020
NHeLP Comments on HHS Regulations Rule (aka SUNSET Rule)
Wayne Turner and Dania Douglas
In the Regulations Rule, HHS seeks to retroactively impose a mandatory expiration date on an estimated 18,000 duly promulgated…
July 20, 2020
NHeLP comments on Medicaid Prescrption Drug Rebate Program and Value- based Purchasing Proposed Rulemaking
Wayne Turner, Elizabeth McCaman, Madeline Morcelle, and Cathren Cohen
In a proposed rule, CMS seeks to expand value-based purchasing arrangements for prescription drugs in commercial plans and the…
June 19, 2020
HHS Eliminates or Weakens Regulatory Protections Against Discrimination in Health Care
Wayne Turner, Mara Youdelman, and Madeline Morcelle
As part of its ongoing attacks on health care and civil rights, the Trump administration recently finalized drastic changes…

Edmunds v. Levine, Southern District of Florida

Executive Summary

Related Content

NHeLP Comments on HHS Regulations Rule (aka SUNSET Rule)

NHeLP comments on Medicaid Prescrption Drug Rebate Program and Value- based Purchasing Proposed Rulemaking

HHS Eliminates or Weakens Regulatory Protections Against Discrimination in Health Care